Latest in Ozempiclike Drug Failed
Sort by
48 items
-
-
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.The Wall Street Journal - Jan. 24 -
Bain buys 340-year-old pharma company to fast-track Japan’s drug development
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicineFinancial Times - 11h -
I’ve Coached Hundreds of Leaders. The Same Dangerous Mindset Keeps Them Failing
This is the mindset that leads to bad leadership. Here’s how to fix it.Inc. - 1d